375 related articles for article (PubMed ID: 16937447)
1. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.
Zhang W; Dong SF; Sun SH; Wang Y; Li GD; Qu D
World J Gastroenterol; 2006 Aug; 12(29):4727-35. PubMed ID: 16937447
[TBL] [Abstract][Full Text] [Related]
2. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.
Kutzler MA; Robinson TM; Chattergoon MA; Choo DK; Choo AY; Choe PY; Ramanathan MP; Parkinson R; Kudchodkar S; Tamura Y; Sidhu M; Roopchand V; Kim JJ; Pavlakis GN; Felber BK; Waldmann TA; Boyer JD; Weiner DB
J Immunol; 2005 Jul; 175(1):112-23. PubMed ID: 15972637
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques.
Halwani R; Boyer JD; Yassine-Diab B; Haddad EK; Robinson TM; Kumar S; Parkinson R; Wu L; Sidhu MK; Phillipson-Weiner R; Pavlakis GN; Felber BK; Lewis MG; Shen A; Siliciano RF; Weiner DB; Sekaly RP
J Immunol; 2008 Jun; 180(12):7969-79. PubMed ID: 18523260
[TBL] [Abstract][Full Text] [Related]
4. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant effect of plasmid vector-expressed OX40L on candidate DNA vaccine against type B heptatitis].
Du X; Kang Y; Wang X; Wang J; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):357-62. PubMed ID: 19623960
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
Du DW; Jia ZS; Li GY; Zhou YY
World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
[TBL] [Abstract][Full Text] [Related]
8. A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.
Zhang Y; Su WJ; Wang J; Bai XF; Huang CX; Lian JQ
Viral Immunol; 2014 Nov; 27(9):430-7. PubMed ID: 25211639
[TBL] [Abstract][Full Text] [Related]
9. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
Mancini M; Hadchouel M; Tiollais P; Michel ML
J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
[TBL] [Abstract][Full Text] [Related]
11. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.
Kraynyak KA; Kutzler MA; Cisper NJ; Laddy DJ; Morrow MP; Waldmann TA; Weiner DB
Hum Gene Ther; 2009 Oct; 20(10):1143-56. PubMed ID: 19530914
[TBL] [Abstract][Full Text] [Related]
13. Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.
Obeng-Adjei N; Choo DK; Saini J; Yan J; Pankhong P; Parikh A; Chu JS; Weiner DB
Cancer Gene Ther; 2012 Nov; 19(11):779-87. PubMed ID: 23037809
[TBL] [Abstract][Full Text] [Related]
14. beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.
Wang J; Dong S; Liu C; Wang W; Sun S; Gu J; Wang Y; Boraschi D; Qu D
J Biomed Biotechnol; 2010; 2010():645213. PubMed ID: 20625506
[TBL] [Abstract][Full Text] [Related]
15. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
16. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
[TBL] [Abstract][Full Text] [Related]
18. Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice.
Xing YP; Huang ZH; Wang SX; Cai J; Li J; Chou TH; Lu S
World J Gastroenterol; 2005 Aug; 11(29):4583-6. PubMed ID: 16052693
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
20. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8
Chiale C; Moshkani S; Rose JK; Robek MD
Antiviral Res; 2019 Aug; 168():156-167. PubMed ID: 31153968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]